Abeona Therapeutics Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets

Intangible Assets

3 Months Ended

Mar. 31, 2017

Intangible Assets [Abstract]

Intangible Assets

(2) Intangible Assets

Intangible assets consist of the following (in thousands):

	March 31, 2017				December 31, 2016
	Gross carrying value		Accumulated amortization		Gross carrying value		Accumulated amortization
Amortizable intangible assets Licensed technology	$	9,608	$	1,427	$	9,608	$	1,224

Amortization expense related to intangible assets totaled $203,000 for the three months ended March 31, 2017 and totaled $145,000 for the three ended March 31, 2016. The aggregate estimated amortization expense for intangible assets remaining as of March 31, 2017 is as follows (in thousands):

2017	$	610
2018		812
2019		812
2020		812
2021		812
over 5 years		4,323

Total	$	8,181